# @dr.aliciamacpherson on Instagram

- **Type:** Video
- **Original URL:** https://www.instagram.com/p/Dbin3AJEQWe
- **Gondola URL:** https://gondola.cc/posts/68668205-draliciamacpherson-instagram
- **Thumbnail:** https://img.gondola.cc/tr:w-,h-,fo-auto/postThumbnails/4939cb6af4.jpg
- **Posted:** 2026-08-02T14:25:34.000+00:00
- **Account Owner:** Alicia MacPherson (@dr.aliciamacpherson) — https://gondola.cc/dr.aliciamacpherson

## Caption

Everyone’s talking about Ozempic for weight loss… but here’s the part that actually matters. 👀

GLP-1 medications can work.

The strongest data shows 10–15% body weight loss over a year. That’s significant.

But there are 3 things most people skip 👇

1️⃣ Many major trials are funded by the manufacturers.

That doesn’t make the results false, but they must be interpreted carefully.

2️⃣ Weight regain is common after stopping.

Many people regain a large portion within a year.

For most, this isn’t short-term. It’s long-term management.

3️⃣ Side effects are real.

🤢 Nausea

🤮 Vomiting

⚠️ GI discomfort

And long-term safety data in lower-risk individuals is still evolving.

So what does this mean?

GLP-1s can be powerful : especially for women with significant metabolic risk.

But they don’t fix the underlying drivers of weight gain.

If you’re using (or considering) medication, you still need:

🍗 Protein at every meal

🏋️ Strength training to protect muscle

🚶‍♀️ Daily movement

😴 Consistent, quality sleep

🧠 Metabolic stability

Your muscle, movement, and hormone balance are what protect you when the medication stops.

Inside Synctorelease, we focus on building metabolic resilience, whether you’re on medication or not.

If you’re ready to address the root cause, comment “release” below.

#GLP1 #WomensFatLoss #MetabolicHealth #HormoneSupport #InsulinResistance SustainableWeightLoss StrengthTrainingForWomen ProfessionalWomen ReleaseProtocol

## Stats

- **Views:** 179
- **Likes:** 3
- **Shares:** 0
- **Comments:** 0

## Tags

metabolichealth, glp1, hormonesupport, womensfatloss, insulinresistance

---
Copyright (c) Gondola